This technology involves a cell growth-promoting composition and its manufacturing method, created by mixing a sterilized liquid—obtained by removing embryos from 8–12 day embryonated eggs, followed by homogenization, centrifugation, filtration, and sterilization—with serum-free medium and FBS in an 8:1:1 volume ratio. This medium is used to culture and differentiate livestock muscle satellite cells for cultured meat production.
Fetal Bovine Serum (FBS), rich in growth factors, has been a key nutrient in cultured meat media. However, because FBS is obtained by slaughtering pregnant cows to collect fetal blood, it raises significant animal welfare and ethical concerns. Limited supply also drives up production costs, and the paradox of increasing slaughter to produce cultured meat necessitates alternatives that minimize serum use.
This technology utilizes embryonated eggs, where embryos accumulate abundant nutrients and growth factors in the yolk and albumen, as a raw material. Extracts are obtained via ultrasonic homogenization and dilution of the supernatant, then combined with Ham's F-10 serum-free medium. In chicken myoblast cultures, this showed higher growth rates than media containing only FBS; antibiotic mixtures and bFGF can also be added. Applicable to pork, beef, and poultry cultured meat, commercial media production, and muscle cell research, it uses inexpensive embryonated eggs to reduce FBS reliance and establish a foundation for slaughter-free mass production.
This invention was developed with support from the Ministry of Agriculture, Food and Rural Affairs for the development of optimal muscle tissue engineering and mass production systems for cultured meat.
N/A